Gabriele Fischer Selected Research

Neonatal Abstinence Syndrome

10/2016	Monitoring neonatal abstinence syndrome in buprenorphine-exposed in vitro fertilization twins: A case study.
1/2013	Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women.
11/2012	Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
12/2011	Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?
8/2011	Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
7/2011	Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
12/2010	Neonatal abstinence syndrome after methadone or buprenorphine exposure.
4/2010	Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.
1/2009	Association between prenatal tobacco exposure and outcome of neonates born to opioid-maintained mothers. Implications for treatment.
9/2008	Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriele Fischer Research Topics

Disease

15	Neonatal Abstinence Syndrome 10/2016 - 01/2003
13	Opioid-Related Disorders (Opiate Addiction) 01/2020 - 11/2002
9	Substance-Related Disorders (Drug Abuse) 07/2019 - 01/2004
6	Birth Weight (Birth Weights) 10/2016 - 01/2003
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020 - 01/2005
2	Hepatitis C 12/2018 - 04/2009
2	Infections 12/2018 - 04/2009
2	Mental Disorders (Mental Disorder) 01/2018 - 03/2009
1	Antisocial Personality Disorder (Antisocial Personality) 07/2019
1	Gambling (Pathological Gambling) 07/2019
1	Drug Overdose 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Dysthymic Disorder 01/2018
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018
1	Premature Obstetric Labor (Premature Labor) 07/2011
1	Chronic Hepatitis C 06/2011
1	Type 1 Spherocytosis 02/2006
1	Pregnancy Complications 01/2003

Drug/Important Bio-Agent (IBA)

16	Opioid Analgesics (Opioids)IBA 01/2020 - 01/2004
13	Buprenorphine (Subutex)FDA LinkGeneric 01/2018 - 11/2002
12	nasIBA 10/2016 - 01/2003
11	Methadone (Dolophine)FDA LinkGeneric 01/2018 - 11/2002
8	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 11/2002
5	Pharmaceutical PreparationsIBA 01/2018 - 08/2005
3	Cocaine (Cocaine HCl)IBA 01/2019 - 01/2004
3	Heroin (Diamorphine)IBA 09/2006 - 01/2004
2	SolutionsIBA 07/2019 - 01/2013
2	Ribavirin (Virazole)FDA LinkGeneric 06/2011 - 04/2009
2	Illicit Drugs (Recreational Drugs)IBA 03/2009 - 05/2003
1	Naloxone (Narcan)FDA LinkGeneric 01/2020
1	AntibodiesIBA 12/2018
1	Naloxone Drug Combination Buprenorphine FDA Link 01/2013
1	Prescription DrugsIBA 01/2012
1	Nicotine FDA Link 07/2011
1	InterferonsIBA 04/2009
1	Antiviral Agents (Antivirals)IBA 04/2009
1	BenzodiazepinesIBA 01/2008
1	galantide (M 15)IBA 02/2006

Therapy/Procedure

3	Therapeutics 01/2019 - 11/2002
3	Duration of Therapy 08/2011 - 12/2010
3	Length of Stay 08/2011 - 05/2008
1	Opiate Substitution Treatment 07/2019